Prashant R Nambiar Selected Research

Plasminogen Activator Inhibitor 1

5/2003

Defective processing of the transforming growth factor-beta1 in azoxymethane-induced mouse colon tumors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Prashant R Nambiar Research Topics

Disease

17	Neoplasms (Cancer) 01/2021 - 07/2002
5	Body Weight (Weight, Body) 07/2015 - 02/2003
5	Carcinoma (Carcinomatosis) 04/2015 - 01/2006
5	Carcinogenesis 12/2007 - 01/2003
4	Colorectal Neoplasms (Colorectal Cancer) 11/2010 - 01/2003
4	Colonic Neoplasms (Colon Cancer) 05/2008 - 09/2004
3	Adenocarcinoma 04/2015 - 01/2006
3	Inflammation (Inflammations) 01/2007 - 01/2006
2	Adenoma (Adenomas) 04/2015 - 08/2006
2	Colitis 01/2007 - 11/2006
1	Testicular Neoplasms (Testicular Cancer) 01/2021
1	Triple Negative Breast Neoplasms 01/2021
1	Hyperplasia 04/2015
1	Hypertrophy 04/2015
1	Urinary Calculi (Urinary Calculus) 04/2015
1	Liver Cell Adenoma (Hepatocellular Adenoma) 04/2015
1	Transitional Cell Carcinoma 04/2015
1	Graves Disease (Basedow Disease) 08/2014
1	Hyperthyroidism 08/2014
1	Thyrotoxicosis 08/2014
1	Hemangiosarcoma (Angiosarcoma) 01/2013
1	Pheochromocytoma 01/2013
1	Thyroid Neoplasms (Thyroid Cancer) 09/2012
1	Neoplasm Metastasis (Metastasis) 09/2012
1	Hypoxia (Hypoxemia) 09/2012
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 09/2012
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 09/2012
1	Intestinal Neoplasms (Intestinal Cancer) 05/2008
1	Mucinous Adenocarcinoma (Mucinous Carcinoma) 12/2007
1	Gastritis 01/2007
1	Intestinal Polyposis (Polyposis, Intestinal) 01/2006
1	Communicable Diseases (Infectious Diseases) 11/2005
1	Enterotoxemia 06/2005
1	Helicobacter Infections 06/2005
1	Chronic Hepatitis (Chronic Active Hepatitis) 06/2005
1	Adenomatous Polyposis Coli (Familial Adenomatous Polyposis) 09/2004
1	Aberrant Crypt Foci 09/2004

Drug/Important Bio-Agent (IBA)

8	AzoxymethaneIBA 10/2006 - 07/2002
5	Proteins (Proteins, Gene)FDA Link 09/2012 - 07/2002
4	CarcinogensIBA 05/2008 - 01/2003
4	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 05/2008 - 02/2003
3	CytokinesIBA 01/2021 - 01/2006
3	EnzymesIBA 04/2015 - 02/2003
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2006 - 02/2003
3	Complementary DNA (cDNA)IBA 09/2004 - 07/2002
3	Messenger RNA (mRNA)IBA 05/2003 - 07/2002
2	Serine Proteases (Serine Protease)IBA 09/2012 - 05/2003
2	Biomarkers (Surrogate Marker)IBA 11/2010 - 09/2004
2	Prostaglandins EIBA 05/2008 - 02/2003
2	InterleukinsIBA 12/2007 - 08/2006
2	Interleukin-10 (Interleukin 10)IBA 12/2007 - 11/2006
2	beta CateninIBA 09/2004 - 01/2003
2	SolutionsIBA 05/2003 - 02/2003
2	Saline SolutionIBA 05/2003 - 02/2003
2	DNA (Deoxyribonucleic Acid)IBA 02/2003 - 07/2002
1	AntigensIBA 01/2021
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2021
1	antineoplaston A10 (A 10)IBA 07/2015
1	UK 453,061IBA 04/2015
1	Reverse Transcriptase InhibitorsIBA 04/2015
1	Methimazole (Thiamazole)FDA LinkGeneric 08/2014
1	Propylthiouracil FDA Link 08/2014
1	bazedoxifeneIBA 01/2013
1	Sunitinib (Sutent)FDA Link 01/2013
1	AntibodiesIBA 09/2012
1	Carbonic Anhydrase IXIBA 09/2012
1	ProstaglandinsIBA 05/2008
1	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 05/2008
1	Dextrans (Dextran)FDA Link 01/2007
1	sodium sulfate (sodium bisulfate)FDA LinkGeneric 01/2007
1	Drinking WaterIBA 01/2007
1	NF-kappa B (NF-kB)IBA 11/2006
1	Tumor Suppressor Protein p53IBA 10/2006
1	nutlin 3IBA 10/2006
1	Polychlorinated Biphenyls (PCBs)IBA 11/2005
1	Metronidazole (Metric)FDA LinkGeneric 06/2005
1	CDTA (DCTA)IBA 06/2005
1	cytolethal distending toxinIBA 06/2005
1	BismuthIBA 06/2005
1	Anti-Bacterial Agents (Antibiotics)IBA 06/2005
1	Amoxicillin (Wymox)FDA LinkGeneric 06/2005
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 06/2005
1	Proliferating Cell Nuclear Antigen (PCNA)IBA 09/2004
1	Cyclin D1IBA 09/2004
1	RNA (Ribonucleic Acid)IBA 09/2004
1	Plasminogen Activators (Plasminogen Activator)IBA 05/2003
1	Thrombospondin 1IBA 05/2003
1	Fibrinolysin FDA Link 05/2003
1	ImmunosorbentsIBA 05/2003
1	Transforming Growth Factor beta1 (TGF beta 1)IBA 05/2003
1	Plasminogen Activator Inhibitor 1IBA 05/2003
1	Growth InhibitorsIBA 05/2003
1	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 05/2003
1	PlasminogenIBA 05/2003
1	Peptides (Polypeptides)IBA 05/2003
1	LigandsIBA 05/2003

Therapy/Procedure

1	Immunotherapy 01/2021
1	Chemoprevention 05/2008
1	Aftercare (After-Treatment) 12/2007
1	Injections 09/2004